Matricel GmbH signs long-term supply contract with Vericel Corporation
Vericel Corporation (NASDAQ: VCEL), a leading developer of patient-specific cellular therapies, has signed a long-term supply agreement with our member Matricel GmbH ...
Benefit from an effective network of innovative specialists.
Our face-to-face specialist events with experts are open to you. At our networking events, you can get to know the great diversity of the association and make valuable personal contacts in the region and beyond.
